Malignant melanoma stage IV – Basic Information

Go back

Stage IV melanoma represents the most advanced form of this skin cancer, where the disease has traveled beyond its original location to distant parts of the body such as the lungs, liver, brain, bones, or gastrointestinal tract, presenting significant treatment challenges yet offering renewed hope through modern therapies.

What is Stage IV Melanoma?

Stage IV melanoma, also called metastatic melanoma or advanced melanoma, occurs when melanoma cancer cells have spread from their original site in the skin to other organs and tissues throughout the body. This spreading happens through the bloodstream or the lymphatic system, which is the network of vessels and nodes that helps fight infection and remove waste from tissues.[1][2]

When doctors say melanoma has “metastasized,” they mean the cancer has traveled beyond the nearby lymph nodes to more distant locations. The most common places where stage IV melanoma spreads include the lungs, liver, bones, brain, small intestine, and distant areas of skin or soft tissue. Soft tissue includes muscles, nerves, fat, and blood vessels. Sometimes the cancer spreads to just one area, while in other cases it reaches multiple organs at the same time.[2][3]

The staging system used for melanoma comes from the American Joint Committee on Cancer (AJCC). This system uses what’s called TNM scoring, which stands for Tumor, Node, and Metastasis. The “T” describes the original tumor, “N” refers to whether lymph nodes contain cancer, and “M” indicates if the disease has spread to distant body parts. In stage IV melanoma, the cancer qualifies as M1, meaning distant metastasis has occurred, regardless of the size of the original tumor or lymph node involvement.[1][2]

How Common is Stage IV Melanoma and What is the Outlook?

While melanoma represents only about 1% of all skin cancers, it causes the vast majority of skin cancer deaths. The disease can be particularly aggressive when it reaches stage IV. Historically, the outlook for people with metastatic melanoma was quite grim, with 10-year survival rates below 10% and historical 5-year survival rates around 35%.[6][10]

However, the landscape has changed dramatically. Thanks to newer treatment approaches developed over the past decade, particularly immunotherapy drugs called checkpoint inhibitors, survival rates have improved significantly. Some medical centers now report that survival rates have increased to approximately 50%, and there are documented cases where advanced melanoma has been controlled for years or even cured in some patients.[6][8]

It’s important to understand that survival statistics are estimates based on large groups of people and don’t predict what will happen to any individual person. Many factors influence how someone responds to treatment, including their age, overall health, where the cancer has spread, how well they respond to therapy, and what new treatment options become available during their care.[6]

⚠️ Important
The location where melanoma has spread affects prognosis. Research involving over 1,500 patients with stage IV melanoma found that those with cancer in the skin, lymph nodes, or gastrointestinal tract had a median survival of 12.5 months, while those with lung-only metastases had 8.3 months, and those with liver, brain, or bone involvement had 4.4 months. The presence of elevated lactate dehydrogenase (LDH) in the blood also signals a worse prognosis.[10]

Recognizing Signs and Symptoms

The symptoms of stage IV melanoma depend on where the cancer has spread. Because melanoma at this stage has traveled to distant organs, symptoms can vary widely from person to person. Some people may notice new or changing moles or skin lesions appearing in areas far from the original melanoma. These can look like dark spots, raised bumps, or open sores that won’t heal.[6]

When melanoma spreads to internal organs, it can cause symptoms related to those specific locations. For example, if cancer reaches the lungs, a person might experience persistent cough, shortness of breath, or chest pain. Metastases to the liver might cause abdominal pain, yellowing of the skin and eyes (a condition called jaundice), or unexplained weight loss. Brain metastases can lead to headaches, seizures, confusion, vision problems, or changes in behavior and personality.[6]

General symptoms that can occur with advanced melanoma include fatigue that doesn’t improve with rest, loss of appetite, unintentional weight loss, and a general feeling of being unwell. Some people develop swelling in distant lymph nodes that can be felt under the skin. Bone metastases may cause pain in the affected areas or make bones more fragile and prone to breaking.[6]

Treatment Options for Stage IV Melanoma

Treatment for stage IV melanoma aims to control the cancer’s growth, relieve symptoms, and in some cases, can lead to long-term remission or even cure. The approach has changed dramatically over the past 10 to 15 years, with treatment options expanding greatly. Today, treatment frequently combines different approaches such as surgery, immunotherapy, and targeted therapy.[1][7]

Immunotherapy

Immunotherapy has revolutionized the treatment of advanced melanoma. These drugs work by helping the body’s own immune system recognize and attack cancer cells more effectively. Several immunotherapy drugs are now available, and they represent a major breakthrough in melanoma care.[13]

The most commonly used immunotherapy drugs include nivolumab (Opdivo), pembrolizumab (Keytruda), and ipilimumab (Yervoy). These medications are called checkpoint inhibitors because they block proteins that prevent the immune system from attacking cancer. Some patients receive a single immunotherapy drug, while others might be treated with combinations like nivolumab plus ipilimumab. Treatment with checkpoint inhibitors offers the best chances of achieving long-term control or cure of advanced melanoma.[6][13]

These drugs are given through a needle into a vein by infusion. How often and how long immunotherapy continues depends on the specific medication used and how well a person responds. Some patients experience remarkable, durable responses where the cancer shrinks significantly or disappears entirely for years.[13]

Targeted Therapy

Targeted therapy uses drugs designed to attack specific molecular changes or mutations in cancer cells. About half of melanomas have a mutation in a gene called BRAF. For patients whose tumors have this BRAF mutation, targeted therapy drugs can be highly effective.[13]

Common targeted therapy combinations include dabrafenib (Tafinlar) with trametinib (Mekinist), vemurafenib (Zelboraf) with cobimetinib (Cotellic), or encorafenib (Braftovi) with binimetinib (Mektovi). These drugs are taken as pills by mouth daily. They work by blocking signals that tell melanoma cells to grow and divide. For some patients whose melanoma has a different mutation called C-KIT, a drug called imatinib (Gleevec) may be an option.[13]

Targeted therapies often work quickly to shrink tumors, sometimes within weeks. However, their effects may be temporary as cancer cells can develop resistance over time. How long treatment continues depends on how well it’s working and what side effects occur.[13]

Surgery

While surgery is rarely used as the main treatment for stage IV melanoma, it can be helpful in certain situations. If cancer has spread to just one or a few small areas that can be safely removed, surgery might be recommended. This is most likely when metastases are limited to the skin, a single group of lymph nodes, or isolated spots in organs like the lung, liver, brain, or small intestine.[2][13]

The type of surgery performed depends entirely on where the cancer has spread and whether removing it is technically possible without causing significant harm. In some cases, surgery is combined with other treatments like immunotherapy or targeted therapy to improve outcomes.[2]

Radiation Therapy

Radiation therapy uses high-energy rays to destroy cancer cells. For stage IV melanoma, radiation is commonly used to treat metastases in specific locations, particularly the brain or bones. It can effectively relieve pain, reduce tumor size, and prevent complications like bone fractures or pressure on the spinal cord. Radiation therapy can also be used as palliative treatment, meaning its main goal is to ease symptoms and improve quality of life rather than cure the disease.[2][13]

Other Treatment Approaches

Several other treatments may be used for stage IV melanoma in specific situations. For melanoma that has spread to areas of skin or nearby tissues that cannot be removed by surgery, doctors might use localized treatments. One option is injecting immunotherapy drugs directly into tumors, a technique called intralesional therapy. A drug called talimogene laherparepvec (T-VEC), which is a modified virus that attacks cancer cells, can be injected this way.[2][13]

For melanoma confined to an arm or leg, specialized techniques called isolated limb perfusion or isolated limb infusion can deliver high doses of chemotherapy directly to that limb. Another approach called electrochemotherapy combines chemotherapy with electrical pulses to help the drugs enter cancer cells more effectively.[2][13]

Traditional chemotherapy delivered through the bloodstream is generally used only when patients cannot receive immunotherapy or targeted therapy, or when those treatments have stopped working. Single-agent chemotherapy typically produces response rates of only 5% to 20%, and combination chemotherapy, while achieving higher response rates around 40%, doesn’t improve survival and causes more side effects.[10][12]

Clinical Trials

Clinical trials play a crucial role in treating stage IV melanoma. These research studies test new treatments or new combinations of existing treatments to find better ways to help patients. Given the rapid development of new drugs and treatment approaches for melanoma, doctors strongly encourage patients with stage IV disease to consider participating in clinical trials, both when first starting treatment and if the disease progresses despite therapy.[1][7]

Clinical trials offer access to cutting-edge treatments that may not yet be available outside of research settings. They also contribute to advancing medical knowledge that will help future patients. Participation in a clinical trial doesn’t mean giving up standard treatment options, and patients who join trials are closely monitored by medical teams.[1]

Factors Affecting Treatment Decisions

Many factors influence which treatment approach is best for any individual patient with stage IV melanoma. Doctors consider where in the body the melanoma has spread, since different locations may respond better to different therapies. The presence or absence of specific gene mutations like BRAF is critical because it determines whether targeted therapy is an option.[2][13]

A person’s overall health and fitness level matter greatly. Someone who is otherwise healthy may tolerate more intensive treatments or combinations of therapies better than someone with other serious medical conditions. Age can also play a role, though older adults who are otherwise healthy can often do well with aggressive treatment.[2]

Patient preferences are equally important. Some treatments require frequent hospital visits for infusions, while others involve taking pills at home. Side effects vary between different treatment approaches, and patients should discuss with their medical team what to expect and what matters most to them in terms of quality of life during treatment.[2]

⚠️ Important
Before starting treatment for stage IV melanoma, tumors are typically tested for specific genetic mutations, particularly BRAF and sometimes C-KIT. This testing helps doctors determine whether targeted therapy drugs will work. Knowing your tumor’s molecular characteristics is essential for choosing the most effective treatment approach. Don’t hesitate to ask your doctor whether genetic testing of your cancer has been done and what the results showed.

Living with Stage IV Melanoma

Living with advanced melanoma involves not just medical treatment but also addressing emotional, psychological, and practical challenges. Many people experience a range of intense emotions including anxiety, fear, anger, sadness, guilt, and uncertainty about the future. These feelings are completely normal responses to a serious diagnosis.[16]

Healthcare teams recognize that addressing emotional and psychological needs is just as important as treating the cancer itself. Many medical centers offer support services including counseling, support groups, and connections with other patients who have faced similar challenges. Talking with others who truly understand what you’re going through can provide comfort and practical advice.[16]

While much about a cancer diagnosis feels beyond control, focusing on factors you can influence often helps. This might include maintaining good nutrition, staying as physically active as possible within your abilities, getting adequate sleep, managing stress through relaxation techniques or meditation, and staying connected with loved ones. Some research suggests these lifestyle factors may support better treatment outcomes and overall wellbeing, though more studies are needed.[16]

Practical matters like managing medical appointments, handling insurance and financial issues, and coordinating care between different doctors can feel overwhelming. Don’t hesitate to ask for help from family, friends, or professional patient advocates. Many hospitals have social workers or patient navigators who specialize in helping people manage these challenges.[16]

The Importance of Hope and New Developments

While stage IV melanoma remains a serious diagnosis, there are genuine reasons for hope. The treatment landscape has been completely transformed over the past 15 years. Treatments that didn’t exist a decade ago are now keeping people with advanced melanoma alive and well for years. Some patients who would have had very limited options in the past are now experiencing long-term remissions or even cures.[8]

Research continues at a rapid pace, with new drugs, new combinations, and new approaches being tested in clinical trials constantly. Each advance builds on previous knowledge, steadily improving outcomes. The speed at which new treatments are being developed and approved means that options available today may be just the beginning of what becomes possible in the near future.[8]

Many patients find strength in knowing they’re part of a larger community of people facing melanoma, supported by dedicated researchers, doctors, and advocates working tirelessly to improve treatments and ultimately find a cure. Connecting with patient advocacy organizations can provide valuable information, support, and opportunities to contribute to research efforts.[16]

Ongoing Clinical Trials on Malignant melanoma stage IV

  • Study of Regorafenib with BRAF/MEK-Inhibitor Combination for Patients with Advanced Melanoma After Previous Treatment

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium
  • A study of ipilimumab and nivolumab to observe immune system changes in patients with unresectable stage III or IV melanoma

    Not yet recruiting

    1 1 1
    Investigated drugs:
    The Netherlands
  • Study of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies

    Not recruiting

    1 1 1
    Investigated drugs:
    Germany Italy Poland Spain
  • Study of local treatment options for large metastases in patients with BRAF V600 mutated melanoma receiving Encorafenib and Binimetinib combination therapy

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Germany
  • Study of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark Finland France +7
  • Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1
    Investigated drugs:
    Norway Slovakia Sweden
  • Study on the Safety and Effects of ATL001 and Nivolumab for Adults with Metastatic or Recurrent Melanoma

    Not recruiting

    1 1 1
    Investigated drugs:
    Spain
  • Study on the Effectiveness and Safety of RO7198457 and Pembrolizumab for Patients with Untreated Advanced Melanoma

    Not recruiting

    1 1 1
    Germany Spain
  • Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with BRAF V600E/K Mutation-Positive Melanoma After Anti-PD-1 Therapy

    Not recruiting

    1 1 1
    Germany Italy Poland Slovakia Spain
  • Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

    Not recruiting

    1 1
    Investigated drugs:
    Greece Hungary Romania

References

https://www.curemelanoma.org/about-melanoma/melanoma-staging/stage-4-melanoma

https://www.cancerresearchuk.org/about-cancer/melanoma/stages-types/stage-4

https://www.aimatmelanoma.org/stages-of-melanoma/stage-iv/

https://www.mskcc.org/cancer-care/types/melanoma/diagnosis/melanoma-stages

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iv-melanoma

https://www.medicalnewstoday.com/articles/322765

https://www.curemelanoma.org/about-melanoma/melanoma-staging/stage-4-melanoma

https://www.mskcc.org/news/changing-melanoma-landscape-how-research-has-improved-outlook-people-advanced-disease

https://www.cancer.gov/types/skin/patient/melanoma-treatment-pdq

https://pmc.ncbi.nlm.nih.gov/articles/PMC2737459/

https://emedicine.medscape.com/article/2006810-overview

https://pubmed.ncbi.nlm.nih.gov/7805002/

https://cancer.ca/en/cancer-information/cancer-types/melanoma-skin/treatment/metastatic

https://www.cancer.gov/types/skin/hp/melanoma-treatment-pdq

https://www.curemelanoma.org/about-melanoma/melanoma-staging/stage-4-melanoma

https://www.curemelanoma.org/blog/practical-recommendations-for-surviving-and-thriving-despite-melanoma

https://www.cancerresearchuk.org/about-cancer/melanoma/stages-types/stage-4

https://www.mdanderson.org/cancerwise/stage-iv-melanoma-survivor–an-immunotherapy-drug-gave-me-my-life-back.h00-159385890.html

https://www.aimatmelanoma.org/stages-of-melanoma/stage-iv/

https://my.clevelandclinic.org/health/diseases/14391-melanoma

https://www.cancer.org/cancer/types/melanoma-skin-cancer/after-treatment/follow-up.html

FAQ

Can stage IV melanoma be cured?

Yes, stage IV melanoma can sometimes be cured, particularly with newer immunotherapy treatments called checkpoint inhibitors. While not every patient is cured, some people achieve complete responses where all detectable cancer disappears and stays away for many years. Medical centers report that newer treatments can control advanced melanoma for years and even cure it in some cases, though cure is not guaranteed for everyone.

How long can you live with stage 4 melanoma?

Life expectancy with stage IV melanoma varies greatly depending on many factors including where the cancer has spread, how well it responds to treatment, and the person’s overall health. Current 5-year survival rates are around 35-50%, which is much better than in the past. Some people live many years with their disease controlled by treatment. Survival statistics are averages and don’t predict what will happen to any individual person.

What are the best treatment options for stage IV melanoma?

The best treatment options typically include immunotherapy drugs like nivolumab, pembrolizumab, or ipilimumab, which help the immune system fight cancer. For patients whose tumors have a BRAF mutation, targeted therapy drugs like dabrafenib with trametinib can be very effective. Treatment often combines different approaches and may include surgery for limited metastases or radiation therapy for specific sites. Clinical trials testing new treatments are also strongly recommended options.

What does it mean when melanoma spreads to the brain?

When melanoma spreads to the brain, it means cancer cells have traveled through the bloodstream and formed new tumors in the brain tissue. This can cause symptoms like headaches, seizures, confusion, vision problems, or personality changes. Brain metastases are typically treated with radiation therapy, immunotherapy, targeted therapy if the tumor has a BRAF mutation, or sometimes surgery if there are only one or a few spots that can be safely removed.

Should I join a clinical trial for stage 4 melanoma?

Clinical trials are strongly recommended for people with stage IV melanoma. Because new treatments are being developed rapidly, clinical trials offer access to cutting-edge therapies that may work better than current standard treatments. They also help advance medical knowledge to benefit future patients. Patients are encouraged to discuss clinical trial options with their doctors both when starting treatment and if the disease progresses.

🎯 Key takeaways

  • Stage IV melanoma means cancer has spread to distant organs, most commonly the lungs, liver, brain, bones, or gastrointestinal tract, but modern treatments have dramatically improved survival rates over the past decade.
  • Immunotherapy with checkpoint inhibitors has revolutionized treatment and can lead to long-term remissions or even cures in some patients, with survival rates increasing from 25% to approximately 50%.
  • Targeted therapy is highly effective for patients whose melanoma has BRAF or C-KIT mutations, making genetic testing of tumors essential for choosing the right treatment approach.
  • Where the melanoma has spread significantly affects prognosis, with skin and gastrointestinal metastases generally having better outcomes than liver, brain, or bone involvement.
  • Treatment options have expanded dramatically to include immunotherapy, targeted therapy, surgery for limited metastases, radiation therapy, and specialized local treatments, often used in combination.
  • Clinical trials are strongly recommended because they provide access to the newest treatments and help advance medical knowledge that benefits future patients.
  • Survival statistics are estimates based on large groups and don’t predict individual outcomes, with many factors including age, treatment response, and overall health influencing results.
  • Living with stage IV melanoma involves managing not just physical symptoms but also emotional, psychological, and practical challenges, making support services and connections with other patients valuable resources.